Dietary control of stem cells in physiology and cancer
生理学和癌症中干细胞的饮食控制
基本信息
- 批准号:9213850
- 负责人:
- 金额:$ 40.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-23 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdultAgingAgonistBiological AssayBiologyCell physiologyCellsCellular biologyColon CarcinomaCuesDaughterDevelopmentDietDiseaseEngineeringEnzymesEpidemiologyFatty AcidsFoundationsGeneticGenetic TranscriptionHeterogeneityHigh Fat DietIncidenceIntestinal Intraepithelial NeoplasiaIntestinal NeoplasmsIntestinesLGR5 geneLesionLinkMaintenanceMalignant NeoplasmsMammalsMapsMediatingMessenger RNAMetabolicMusNatural regenerationObesityOrganoidsPPAR alphaPPAR deltaPathway interactionsPharmacologyPhysiologyPopulationPremalignantProcessProductionRegulator GenesRodentRoleSignal TransductionStem cellsTestingTherapeuticTransplantationTumor InitiatorsTumor Suppressor GenesTumor Suppressor ProteinsTumorigenicitycell typedelta opioid receptordietary controlexperimental studyfatty acid oxidationin vivointestinal epitheliumintestinal homeostasismouse modeloxidationprogenitorprogramsresponseself-renewalstem cell biologystemnesstissue regenerationtumortumor initiationtumorigenesistumorigenic
项目摘要
PROJECT SUMMARY
Organismal diet has a profound impact on tissue regeneration, aging, and disease in mammals. However, the
mechanisms through which diet perturbs stem and progenitor cell biology and leads to diseases such as
cancer are poorly understood. With the rise of obesity in the US population—more than 1 in 3 adults are obese
–understanding the relationship between diet, stem cell biology, and cancer incidence takes on great
importance.
Focused on the mammalian intestine, we find that a pro-obesity high fat diet (HFD) augments the number
and niche-independent function of Lgr5+ stem cells. Mechanistically, our studies indicate that a HFD induces a
robust peroxisome proliferator-activated receptor delta (PPAR-d) signature in intestinal stem cells (ISCs) and
progenitors (non-stem cells), and pharmacologic activation of PPAR-d recapitulates the effects that a HFD has
on these cells. Furthermore, like a HFD, ex vivo treatment of intestinal organoid cultures with fatty acid
constituents of the HFD enhances the self-renewal potential of these organoids in a PPAR-d dependent
manner. Interestingly, both HFD- and agonist-activated PPAR-d signaling endow progenitors with the
organoid-initiating capacity normally restricted to stem cells. In fact, agonist-enforced PPAR-d signaling permits
these progenitors to form in vivo tumors upon loss of the tumor suppressor Apc. These observations provide a
possible pathway for diet through modulating PPAR-d activation to alter not only the function of intestinal stem
and progenitor cells but also their capacity to initiate tumors. Many questions remain regarding the impact of a
HFD on the intestine, such as the in vivo, cell type-specific roles of PPAR-d in this process, and the identity of
progenitor subsets that emerge in this diet to drive tumor development. Also, although PPAR-d is a master
transcriptional regulator of genes involved in fatty acid oxidation (FAO), it is unclear whether intestinal stem
and progenitor cells or tumors that arise in a HFD rely on this PPAR-d-activated FAO metabolic program for
their maintenance.
Specifically, we will test the hypotheses that PPAR-d mediates the in vivo effects of a HFD in ISCs and
progenitors in intestinal homeostasis and tumor initiation (Aim 1); that a subset of non-stem cell progenitors
acquire stemness and tumorigenic potential in a HFD and with enforced PPAR-d signaling (Aim 2); that a HFD
or enforced PPAR-d signaling render ISCs, progenitors, or established tumors metabolically reliant on fatty
acid oxidation for their maintenance (Aim 3).
项目摘要
有机饮食对哺乳动物的组织再生、衰老和疾病有着深远的影响。但
饮食干扰干细胞和祖细胞生物学并导致疾病的机制,
癌症知之甚少。随着美国人口肥胖率的上升--超过三分之一的成年人肥胖
了解饮食、干细胞生物学和癌症发病率之间的关系,
重要性
聚焦于哺乳动物的肠道,我们发现促肥胖高脂肪饮食(HFD)增加了
和Lgr 5+干细胞的小生境非依赖性功能。从机制上讲,我们的研究表明HFD会诱导
肠干细胞(ISCs)中强过氧化物酶体增殖物激活受体δ(PPAR-d)特征,
祖细胞(非干细胞),PPAR-d的药理学激活概括了HFD具有的作用,
这些细胞。此外,像HFD一样,用脂肪酸对肠类器官培养物进行离体处理是可行的。
HFD的成分增强了这些类器官的自我更新潜力,
方式有趣的是,HFD和激动剂激活的PPAR-d信号转导都赋予祖细胞以特异性的转录因子。
类器官启动能力通常仅限于干细胞。事实上,激动剂增强的PPAR-d信号传导允许
这些祖细胞在失去肿瘤抑制因子Apc后形成体内肿瘤。这些观察提供了一个
饮食可能通过调节PPAR-d的活化,不仅改变肠干的功能,
和祖细胞,以及它们引发肿瘤的能力。许多问题仍然存在的影响,
HFD对肠的影响,如PPAR-d在该过程中的体内细胞类型特异性作用,以及
这种饮食中出现的祖细胞亚群推动肿瘤发展。此外,虽然PPAR-d是一个主
转录调控基因参与脂肪酸氧化(粮农组织),目前还不清楚是否肠干
HFD中出现的祖细胞或肿瘤依赖于这种PPAR-d激活的FAO代谢程序,
他们的维护。
具体而言,我们将检验PPAR-d介导HFD在ISCs中的体内作用的假设,
在肠道内稳态和肿瘤发生(Aim 1)的祖细胞;非干细胞祖细胞的子集
在HFD中获得干性和致瘤潜力,并具有增强的PPAR-d信号传导(目的2); HFD
或增强的PPAR-d信号传导使ISCs、祖细胞或已建立的肿瘤在代谢上依赖于脂肪代谢。
酸氧化以维持它们(目标3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Omer Yilmaz其他文献
Omer Yilmaz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Omer Yilmaz', 18)}}的其他基金
Impact of fasting on intestinal stem cells and cancer
禁食对肠道干细胞和癌症的影响
- 批准号:
10653895 - 财政年份:2020
- 资助金额:
$ 40.95万 - 项目类别:
Impact of fasting on intestinal stem cells and cancer
禁食对肠道干细胞和癌症的影响
- 批准号:
10238167 - 财政年份:2020
- 资助金额:
$ 40.95万 - 项目类别:
Impact of fasting on intestinal stem cells and cancer
禁食对肠道干细胞和癌症的影响
- 批准号:
10403548 - 财政年份:2020
- 资助金额:
$ 40.95万 - 项目类别:
Dietary control of stem cells in physiology and cancer
生理学和癌症中干细胞的饮食控制
- 批准号:
10058815 - 财政年份:2016
- 资助金额:
$ 40.95万 - 项目类别:
Regulation of the Intestinal Stem Cell Niche in Aging
衰老过程中肠道干细胞生态位的调节
- 批准号:
8919197 - 财政年份:2014
- 资助金额:
$ 40.95万 - 项目类别:
Regulation of the Intestinal Stem Cell Niche in Aging
衰老过程中肠道干细胞生态位的调节
- 批准号:
8900580 - 财政年份:2014
- 资助金额:
$ 40.95万 - 项目类别:
Regulation of the Intestinal Stem Cell Niche in Aging
衰老过程中肠道干细胞生态位的调节
- 批准号:
8560030 - 财政年份:2013
- 资助金额:
$ 40.95万 - 项目类别:
Regulation of the Intestinal Stem Cell Niche in Aging
衰老过程中肠道干细胞生态位的调节
- 批准号:
8726277 - 财政年份:2013
- 资助金额:
$ 40.95万 - 项目类别:
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 40.95万 - 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
- 批准号:
10660046 - 财政年份:2023
- 资助金额:
$ 40.95万 - 项目类别:
Understanding Longer-Living Older Adult Research: The Summer Program on Aging
了解长寿老年人研究:老龄化夏季项目
- 批准号:
476343 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Role of sensory experience in the regulation of plasticity in the developing, adult and aging brain
感官体验在发育、成人和衰老大脑可塑性调节中的作用
- 批准号:
RGPIN-2019-04761 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Discovery Grants Program - Individual
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10365348 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10700796 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10651861 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Investigating the interface of epigenetics and metabolism underlying memory formation in the adult, aging, and AD brain
研究成人、衰老和 AD 大脑中记忆形成的表观遗传学和代谢界面
- 批准号:
10420533 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10846200 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:
THE DEVELOPMENT OF MECHANISM-BASED ADULT STEM CELL TREATMENTS TO COMBAT AGING PATHOLOGIES
开发基于机制的成人干细胞疗法来对抗衰老病理学
- 批准号:
10721544 - 财政年份:2022
- 资助金额:
$ 40.95万 - 项目类别:














{{item.name}}会员




